We Give Shareholders a Voice
Levi & Korsinsky, LLP has commenced an investigation into the fairness of the sale of AveXis, Inc. (NASDAQGS: AVXS) to Novartis (NYSE: NVS) for $218 per share. The transaction has a total approximate value of $8.7 billion.
The investigation concerns whether the Board of AveXis breached their fiduciary duties to stockholders by failing to adequately shop the Company before agreeing to enter into this transaction, and whether Novartis is underpaying for AveXis shares, thus unlawfully harming Connecticut Water shareholders.
To receive more information, please fill out the form.